Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan

Published:2020-08-01 Issue:4 Volume:21 Page:829-836
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Wang Xin¹,Chen Hua¹,E Essien¹,Wu Jun²,Serna Omar³,Paranjpe Rutugandha¹,Abughosh Susan¹

Affiliation:

1. Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX, USA

2. Department of Pharmaceutical and Administrative Sciences, Presbyterian College School of Pharmacy, Clinton, SC, USA

3. CareAllies, Houston, TX, USA

Funder

funding obtained

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2020.1800457

Reference55 articles.

1. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

2. Combination therapy for the management of hypertension: A review of the evidence

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of adherence on the cost-effectiveness of apixaban and rivaroxaban in stroke prevention among patients with atrial fibrillation in the United States;Expert Review of Pharmacoeconomics & Outcomes Research;2024-09-03

2. Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study;BMC Public Health;2024-07-06

3. Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review;Frontiers in Pharmacology;2024-02-08

4. Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure;Heart;2023-07-26

5. Cost-effectiveness analysis of initial treatment with single-pill combination antihypertensive medications;Journal of Human Hypertension;2023-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3